Blocking MARCO+ tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway
- Resource Type
- Article
- Source
- In
Cancer Letters 1 February 2024 582 - Subject
- Language
- ISSN
- 0304-3835